Psychedelics Shake Up Psychiatry

How ecstasy and psilocybin are shaking up psychiatry. (Nature, 2021)

Carhart-Harris Psychedelic App

The MyDelica app "offers a personalized progress tracker and evidence-based advice service for educating & safeguarding psychedelic journeys"

No idea about this, but being as it is from the Robin Carhart-Harris team, might be worth a look for people seeking safe and therapeutic experiences.

Psilocybin Relieves Depression

Psilocybin showed significant effectiveness against major depression, much more powerful than psychotherapy or antidepressants.

Screened participants were given a moderately high dose of 20mg/70kg (perhaps 4.5 grams mushrooms for a 70kg person) and a week and a half later were given a high dose of 30mg/70kg (perhaps 6.7 grams / 70 kg).

"These data expand the findings of previous studies involving patients with cancer and depression as well as patients with treatment-resistant depression by suggesting that psilocybin may be effective in the much larger population of MDD. Further studies are needed with active treatment or placebo controls and in larger and more diverse populations."

Oregon legalizes, DC & Oregon decriminalize psychedelics

Oregon legalizes psilocybin for therapeutic use and decriminalizes a number of substances.

Washington D.C. categorizes psychedelic plants and fungi as “the lowest level police enforcement priority.”

 

LSD-MDMA "Candyflipping" Clinical Trial

I feel like we're living in bizarro world as a combination LSD and MMDA clinical trial is set to begin later this year.

Finders Paper Published

The material from the Finders Course research that has been available as a continually updated white paper on the Non-Symbolic website has now been finalized and published in an open access journal.

Psychedelics help individuals accept emotions

Psychedelic drugs reduce depressive symptoms by helping individuals accept their emotions, study suggests

"the use of psychedelics in both ceremonial and non-ceremonial settings was associated with decreases in experiential avoidance, which in turn was associated with decreases in depression severity and suicidal ideation 4-weeks after psychedelic use.

Our findings suggest that one of the reasons that psychedelic therapy has positive therapeutic effects is that it helps individuals to be less avoidant and more accepting of their emotions, thoughts, and memories (even though such experiences may be distressing in the short-term)

More broadly, our results provide further support for the negative mental health effects associated with avoidance. This can be summed up with a saying that is often used in the context of psychedelic therapy, that ‘The only way out is through.'"